Get started
Award

SZSM201602102

Funded outputs count: 7
Funder award ID: SZSM201602102
OpenAlex ID: G809593454
A versatile NiS2/FeS2 hybrid nanocrystal for synergistic cancer therapy by inducing ferroptosis and pyroptosis
2023 · Shuxiang Xu, Shuyi Zhou, et al. · Chemical Engineering Journal · 32
An ultrasmall PVP–Fe–Cu–Ni–S nano-agent for synergistic cancer therapy through triggering ferroptosis and autophagy
2023 · Rongjun Zhang, Shuxiang Xu, et al. · Nanoscale · 8
RNA-Seq Based Toxicity Analysis of Mesoporous Polydopamine Nanoparticles in Mice Following Different Exposure Routes
2022 · Zihua Huang, Luoyijun Xie, et al. · Frontiers in Bioengineering and Biotechnology · 6
PDF
hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allografts
2020 · Dilyana Todorova, Yue Zhang, et al. · EBioMedicine · 14
Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics
2020 · Qingke Li, Qu Chen, et al. · Cell · 215
PDF
Bicompatible porous Co3O4 nanoplates with intrinsic tumor metastasis inhibition for multimodal imaging and DNA damage–mediated tumor synergetic photothermal/photodynamic therapy
2020 · Miaomiao Yuan, Shuxiang Xu, et al. · Chemical Engineering Journal · 37
Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation
2019 · Jinchul Kim, Lili Yu, et al. · Cancer Cell · 202
PDF
Year
Topic